Epidermal Growth Factor Receptor-2 (HER2)-positive breast cancers (BCs) are carcinomas characterized by the amplification and overexpression of the HER2 tyrosine kinase receptor gene (17q12), and they account for 15–20% of all BCs [1]. The gene discussed is ERBB2; the disease is carcinoma.